{
  "release_id": "a25293eeae6350fb",
  "id": "cardio:cardiotoxicity-from-cancer-treatment",
  "owner": "cardio",
  "kind": "condition",
  "slug": "cardiotoxicity-from-cancer-treatment",
  "name": "Cardiotoxicity from cancer treatment",
  "aliases": [
    "Cancer therapy-related cardiovascular toxicity",
    "Cardiotoxicity"
  ],
  "atlases": [
    "cardio"
  ],
  "summary_plain": "Cardiotoxicity from cancer treatment means damage to the heart or its function caused by cancer treatments such as chemotherapy, immunotherapy or radiation. A 2025 review says these treatments have increased survival but are frequently linked to cardiovascular toxicity, which has a significant impact on outcomes and well-being. The review says the changes can lead to conditions such as cardiomyopathy and can result in heart failure and sudden cardiac death.",
  "summary_technical": "MeSH Cardiotoxicity (D066126) is recorded as a broad match: its scope note covers damage to the heart from toxic substances, including chemotherapy, immunotherapy and radiation, and is not limited to cancer care. The description rests on that scope note and on a 2025 review under a CC BY licence (Heart Failure Reviews). The review says there is no universally accepted definition and that the condition is often defined clinically as a reduction in left ventricular ejection fraction. Drug names, risk factors, monitoring and protective strategies in the review are not repeated here. The evidence is descriptive and comes from a narrative review, with no trial data.",
  "editorial_state": "draft",
  "last_substantive_edit": "2026-11-18",
  "last_evidence_check": "2026-11-18",
  "next_review_due": null,
  "identifiers": [
    {
      "scheme": "mesh",
      "value": "D066126",
      "normalized_value": "D066126",
      "match": "broad",
      "version": "MeSH linked-data descriptor record fetched on 2026-11-18, lastUpdated 2019-07-05; the record states no yearly MeSH release",
      "label": null,
      "from_source": false
    }
  ],
  "navigation": {
    "cardio": {
      "system": [
        "heart"
      ],
      "condition-area": [
        "heart-failure"
      ]
    }
  },
  "payload": {
    "recognition": null,
    "assessment": null,
    "burden_claims": []
  },
  "content_digest": "236dbd27bff0068450a0e51859dfce956504cc6ac0bad57b5871f6434113cb8e",
  "review": {
    "content_digest": "236dbd27bff0068450a0e51859dfce956504cc6ac0bad57b5871f6434113cb8e",
    "current": [],
    "conflicting": [],
    "stale": [],
    "inactive": []
  },
  "claims": [
    {
      "release_id": "a25293eeae6350fb",
      "id": "cardio:claim-cardiotoxicity-cancer-treatment-review",
      "owner": "cardio",
      "subject_entity_id": "cardio:cardiotoxicity-from-cancer-treatment",
      "category": "descriptive",
      "statement": "MeSH describes cardiotoxicity as damage to the heart or its function after exposure to toxic substances such as chemotherapy drugs, immunotherapy or radiation. A 2025 narrative review (Heart Failure Reviews) says cancer treatments are frequently linked to cardiovascular toxicity with a significant impact on clinical outcomes and well-being, that there is no universally accepted definition of the condition (it is often defined clinically as a reduction in left ventricular ejection fraction), and that the changes can lead to dilated and restrictive cardiomyopathy and can result in heart failure and sudden cardiac death.",
      "context": {
        "id": "cardio:ctx-cardiotoxicity-cancer-treatment-review",
        "label": "People treated for cancer with chemotherapy, targeted therapy, immunotherapy or radiotherapy (narrative review)",
        "recipient": "unknown",
        "population": "People who have had cancer treatment such as chemotherapy, targeted therapy, immunotherapy or radiotherapy, as the review describes them. The review also mentions long-term studies of childhood cancer survivors.",
        "care_setting": "Cancer treatment and cardio-oncology care, as described in the review.",
        "geography": "Not stated for the review as a whole.",
        "life_stage_note": "Adults and children are not separated here. This record makes no statement about pregnancy, newborns or children.",
        "life_stage_terms": null,
        "gestational_age_min_days": null,
        "gestational_age_max_days": null,
        "gestational_age_basis": null,
        "postnatal_age_min_days": null,
        "postnatal_age_max_days": null,
        "gestational_age_status": null,
        "postnatal_age_status": null,
        "followup_description": "Not applicable (a description of a condition).",
        "eligibility": {
          "inclusion": [
            "Having had cancer treatment that can harm the heart"
          ],
          "exclusion": []
        }
      },
      "evidence_stage": "synthesis",
      "certainty": "not_assessed",
      "certainty_method": null,
      "limitations": "A narrative review and a thesaurus scope note, not a study of how often the damage occurs. The MeSH descriptor is not limited to cancer care. The review gives no risk figures here: its drug names, mechanisms, risk estimates, classification, monitoring and protective strategies are not repeated, and nothing here says who should be monitored or how.",
      "editorial_state": "draft",
      "checked_at": "2026-11-18",
      "next_review_due": null,
      "valid_from": null,
      "valid_to": null,
      "citations": [
        {
          "evidence_role": "supports",
          "locator": "scopeNote.@value, sentence 1",
          "applicability_note": "MeSH scope note: heart damage from chemotherapy, immunotherapy or radiation.",
          "snapshot": {
            "id": "cardio:mesh-scope-d066126-2026-11-18",
            "retrieved_at": "2026-11-18T18:06:08Z",
            "content_hash": "f80e554a493c601a68a23f9ff8b6f60bc0310dc074bd769961c0d895b865f807",
            "source_effective_date": null,
            "public_archive_url": null,
            "source_state": "current"
          },
          "source": {
            "id": "cardio:mesh-scope-d066126",
            "source_type": "dataset",
            "title": "MeSH scope note for descriptor D066126 (Cardiotoxicity)",
            "canonical_url": "https://id.nlm.nih.gov/mesh/M0592728",
            "identifiers": [
              {
                "scheme": "mesh",
                "value": "M0592728",
                "normalized_value": "M0592728",
                "match": "exact",
                "version": "id.nlm.nih.gov linked data, preferred concept M0592728 of descriptor D066126, retrieved 2026-11-18",
                "label": null,
                "from_source": false
              }
            ],
            "publication_date": null,
            "publisher": "U.S. National Library of Medicine",
            "edition": "MeSH linked-data record of the preferred concept M0592728 of descriptor D066126, fetched 2026-11-18. The scope note is on this concept record, not on the descriptor record.",
            "reuse_basis": "The NLM web policies page (sha256 c8b7026b5c3fcfd1b0cb88755077f6a99a5f2159eecd42b0e7d1a5ad9b30ec55, hash only) says works produced by the U.S. government are not subject to copyright protection in the United States and asks users to acknowledge NLM as the source. The NLM MeSH terms and conditions page (sha256 f33b14141a5b6c8a2b1464c751dbdbb0a0d476c913851bf2a8c3d5c14b1afce7, hash only) asks redistributors to maintain current data or to make known that their copy may not reflect the most current data. This copy was fetched on 2026-11-18 and may not reflect the most current data. The raw bytes are committed at research/snapshots/w4k15-meshc-M0592728.json.",
            "public_text": "quote",
            "replaced_by": null,
            "retirement_note": null
          }
        },
        {
          "evidence_role": "supports",
          "locator": "Abstract, sentence 2",
          "applicability_note": "Cancer treatments are frequently linked to cardiovascular toxicity.",
          "snapshot": {
            "id": "cardio:pmc-pmc12297282-2026-11-18",
            "retrieved_at": "2026-11-18T18:09:51Z",
            "content_hash": "1fd62c1ddd41f65aceb23e6c727e3a74174e9abddfb6e23d988bce38d5a34e2c",
            "source_effective_date": null,
            "public_archive_url": null,
            "source_state": "current"
          },
          "source": {
            "id": "cardio:pmc-pmc12297282",
            "source_type": "publication",
            "title": "Cancer therapy-induced cardiotoxicity: mechanisms and mitigations",
            "canonical_url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC12297282/",
            "identifiers": [
              {
                "scheme": "pmcid",
                "value": "PMC12297282",
                "normalized_value": "PMC12297282",
                "match": "exact",
                "version": null,
                "label": null,
                "from_source": false
              },
              {
                "scheme": "pmid",
                "value": "40481994",
                "normalized_value": "40481994",
                "match": "exact",
                "version": null,
                "label": null,
                "from_source": false
              },
              {
                "scheme": "doi",
                "value": "10.1007/s10741-025-10531-0",
                "normalized_value": "10.1007/s10741-025-10531-0",
                "match": "exact",
                "version": null,
                "label": null,
                "from_source": false
              }
            ],
            "publication_date": null,
            "publisher": "Heart Failure Reviews",
            "edition": "PMC Open Access subset full-text XML, from NCBI E-utilities (Heart Failure Reviews, 2025), fetched 2026-11-18. A narrative or literature review. Used only for how the review defines cardiotoxicity from cancer treatment, what it links to and what it says about the heart conditions that can follow; its drug names, mechanisms, risk figures and cardioprotective strategies are not used.",
            "reuse_basis": "PMC Open Access subset article under the Creative Commons Attribution 4.0 licence (https://creativecommons.org/licenses/by/4.0/). The article's own license element states the licence. The XML is committed unaltered, with the citation and licence kept in the file. The raw file is committed at research/snapshots/w4k15-pmc-PMC12297282.xml.",
            "public_text": "quote",
            "replaced_by": null,
            "retirement_note": null
          }
        },
        {
          "evidence_role": "supports",
          "locator": "Introduction, para 2, sentence 2 (first part)",
          "applicability_note": "No universally accepted definition.",
          "snapshot": {
            "id": "cardio:pmc-pmc12297282-2026-11-18",
            "retrieved_at": "2026-11-18T18:09:51Z",
            "content_hash": "1fd62c1ddd41f65aceb23e6c727e3a74174e9abddfb6e23d988bce38d5a34e2c",
            "source_effective_date": null,
            "public_archive_url": null,
            "source_state": "current"
          },
          "source": {
            "id": "cardio:pmc-pmc12297282",
            "source_type": "publication",
            "title": "Cancer therapy-induced cardiotoxicity: mechanisms and mitigations",
            "canonical_url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC12297282/",
            "identifiers": [
              {
                "scheme": "pmcid",
                "value": "PMC12297282",
                "normalized_value": "PMC12297282",
                "match": "exact",
                "version": null,
                "label": null,
                "from_source": false
              },
              {
                "scheme": "pmid",
                "value": "40481994",
                "normalized_value": "40481994",
                "match": "exact",
                "version": null,
                "label": null,
                "from_source": false
              },
              {
                "scheme": "doi",
                "value": "10.1007/s10741-025-10531-0",
                "normalized_value": "10.1007/s10741-025-10531-0",
                "match": "exact",
                "version": null,
                "label": null,
                "from_source": false
              }
            ],
            "publication_date": null,
            "publisher": "Heart Failure Reviews",
            "edition": "PMC Open Access subset full-text XML, from NCBI E-utilities (Heart Failure Reviews, 2025), fetched 2026-11-18. A narrative or literature review. Used only for how the review defines cardiotoxicity from cancer treatment, what it links to and what it says about the heart conditions that can follow; its drug names, mechanisms, risk figures and cardioprotective strategies are not used.",
            "reuse_basis": "PMC Open Access subset article under the Creative Commons Attribution 4.0 licence (https://creativecommons.org/licenses/by/4.0/). The article's own license element states the licence. The XML is committed unaltered, with the citation and licence kept in the file. The raw file is committed at research/snapshots/w4k15-pmc-PMC12297282.xml.",
            "public_text": "quote",
            "replaced_by": null,
            "retirement_note": null
          }
        },
        {
          "evidence_role": "supports",
          "locator": "Introduction, para 2, sentence 2 (second part)",
          "applicability_note": "Often defined clinically as a fall in ejection fraction.",
          "snapshot": {
            "id": "cardio:pmc-pmc12297282-2026-11-18",
            "retrieved_at": "2026-11-18T18:09:51Z",
            "content_hash": "1fd62c1ddd41f65aceb23e6c727e3a74174e9abddfb6e23d988bce38d5a34e2c",
            "source_effective_date": null,
            "public_archive_url": null,
            "source_state": "current"
          },
          "source": {
            "id": "cardio:pmc-pmc12297282",
            "source_type": "publication",
            "title": "Cancer therapy-induced cardiotoxicity: mechanisms and mitigations",
            "canonical_url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC12297282/",
            "identifiers": [
              {
                "scheme": "pmcid",
                "value": "PMC12297282",
                "normalized_value": "PMC12297282",
                "match": "exact",
                "version": null,
                "label": null,
                "from_source": false
              },
              {
                "scheme": "pmid",
                "value": "40481994",
                "normalized_value": "40481994",
                "match": "exact",
                "version": null,
                "label": null,
                "from_source": false
              },
              {
                "scheme": "doi",
                "value": "10.1007/s10741-025-10531-0",
                "normalized_value": "10.1007/s10741-025-10531-0",
                "match": "exact",
                "version": null,
                "label": null,
                "from_source": false
              }
            ],
            "publication_date": null,
            "publisher": "Heart Failure Reviews",
            "edition": "PMC Open Access subset full-text XML, from NCBI E-utilities (Heart Failure Reviews, 2025), fetched 2026-11-18. A narrative or literature review. Used only for how the review defines cardiotoxicity from cancer treatment, what it links to and what it says about the heart conditions that can follow; its drug names, mechanisms, risk figures and cardioprotective strategies are not used.",
            "reuse_basis": "PMC Open Access subset article under the Creative Commons Attribution 4.0 licence (https://creativecommons.org/licenses/by/4.0/). The article's own license element states the licence. The XML is committed unaltered, with the citation and licence kept in the file. The raw file is committed at research/snapshots/w4k15-pmc-PMC12297282.xml.",
            "public_text": "quote",
            "replaced_by": null,
            "retirement_note": null
          }
        },
        {
          "evidence_role": "supports",
          "locator": "Abstract, sentence 5 (first part)",
          "applicability_note": "The changes can lead to cardiomyopathy.",
          "snapshot": {
            "id": "cardio:pmc-pmc12297282-2026-11-18",
            "retrieved_at": "2026-11-18T18:09:51Z",
            "content_hash": "1fd62c1ddd41f65aceb23e6c727e3a74174e9abddfb6e23d988bce38d5a34e2c",
            "source_effective_date": null,
            "public_archive_url": null,
            "source_state": "current"
          },
          "source": {
            "id": "cardio:pmc-pmc12297282",
            "source_type": "publication",
            "title": "Cancer therapy-induced cardiotoxicity: mechanisms and mitigations",
            "canonical_url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC12297282/",
            "identifiers": [
              {
                "scheme": "pmcid",
                "value": "PMC12297282",
                "normalized_value": "PMC12297282",
                "match": "exact",
                "version": null,
                "label": null,
                "from_source": false
              },
              {
                "scheme": "pmid",
                "value": "40481994",
                "normalized_value": "40481994",
                "match": "exact",
                "version": null,
                "label": null,
                "from_source": false
              },
              {
                "scheme": "doi",
                "value": "10.1007/s10741-025-10531-0",
                "normalized_value": "10.1007/s10741-025-10531-0",
                "match": "exact",
                "version": null,
                "label": null,
                "from_source": false
              }
            ],
            "publication_date": null,
            "publisher": "Heart Failure Reviews",
            "edition": "PMC Open Access subset full-text XML, from NCBI E-utilities (Heart Failure Reviews, 2025), fetched 2026-11-18. A narrative or literature review. Used only for how the review defines cardiotoxicity from cancer treatment, what it links to and what it says about the heart conditions that can follow; its drug names, mechanisms, risk figures and cardioprotective strategies are not used.",
            "reuse_basis": "PMC Open Access subset article under the Creative Commons Attribution 4.0 licence (https://creativecommons.org/licenses/by/4.0/). The article's own license element states the licence. The XML is committed unaltered, with the citation and licence kept in the file. The raw file is committed at research/snapshots/w4k15-pmc-PMC12297282.xml.",
            "public_text": "quote",
            "replaced_by": null,
            "retirement_note": null
          }
        },
        {
          "evidence_role": "supports",
          "locator": "Abstract, sentence 5 (end)",
          "applicability_note": "The conditions can result in heart failure and sudden cardiac death.",
          "snapshot": {
            "id": "cardio:pmc-pmc12297282-2026-11-18",
            "retrieved_at": "2026-11-18T18:09:51Z",
            "content_hash": "1fd62c1ddd41f65aceb23e6c727e3a74174e9abddfb6e23d988bce38d5a34e2c",
            "source_effective_date": null,
            "public_archive_url": null,
            "source_state": "current"
          },
          "source": {
            "id": "cardio:pmc-pmc12297282",
            "source_type": "publication",
            "title": "Cancer therapy-induced cardiotoxicity: mechanisms and mitigations",
            "canonical_url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC12297282/",
            "identifiers": [
              {
                "scheme": "pmcid",
                "value": "PMC12297282",
                "normalized_value": "PMC12297282",
                "match": "exact",
                "version": null,
                "label": null,
                "from_source": false
              },
              {
                "scheme": "pmid",
                "value": "40481994",
                "normalized_value": "40481994",
                "match": "exact",
                "version": null,
                "label": null,
                "from_source": false
              },
              {
                "scheme": "doi",
                "value": "10.1007/s10741-025-10531-0",
                "normalized_value": "10.1007/s10741-025-10531-0",
                "match": "exact",
                "version": null,
                "label": null,
                "from_source": false
              }
            ],
            "publication_date": null,
            "publisher": "Heart Failure Reviews",
            "edition": "PMC Open Access subset full-text XML, from NCBI E-utilities (Heart Failure Reviews, 2025), fetched 2026-11-18. A narrative or literature review. Used only for how the review defines cardiotoxicity from cancer treatment, what it links to and what it says about the heart conditions that can follow; its drug names, mechanisms, risk figures and cardioprotective strategies are not used.",
            "reuse_basis": "PMC Open Access subset article under the Creative Commons Attribution 4.0 licence (https://creativecommons.org/licenses/by/4.0/). The article's own license element states the licence. The XML is committed unaltered, with the citation and licence kept in the file. The raw file is committed at research/snapshots/w4k15-pmc-PMC12297282.xml.",
            "public_text": "quote",
            "replaced_by": null,
            "retirement_note": null
          }
        },
        {
          "evidence_role": "context",
          "locator": "Abstract, sentence 1",
          "applicability_note": "Context: the treatments have increased survival.",
          "snapshot": {
            "id": "cardio:pmc-pmc12297282-2026-11-18",
            "retrieved_at": "2026-11-18T18:09:51Z",
            "content_hash": "1fd62c1ddd41f65aceb23e6c727e3a74174e9abddfb6e23d988bce38d5a34e2c",
            "source_effective_date": null,
            "public_archive_url": null,
            "source_state": "current"
          },
          "source": {
            "id": "cardio:pmc-pmc12297282",
            "source_type": "publication",
            "title": "Cancer therapy-induced cardiotoxicity: mechanisms and mitigations",
            "canonical_url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC12297282/",
            "identifiers": [
              {
                "scheme": "pmcid",
                "value": "PMC12297282",
                "normalized_value": "PMC12297282",
                "match": "exact",
                "version": null,
                "label": null,
                "from_source": false
              },
              {
                "scheme": "pmid",
                "value": "40481994",
                "normalized_value": "40481994",
                "match": "exact",
                "version": null,
                "label": null,
                "from_source": false
              },
              {
                "scheme": "doi",
                "value": "10.1007/s10741-025-10531-0",
                "normalized_value": "10.1007/s10741-025-10531-0",
                "match": "exact",
                "version": null,
                "label": null,
                "from_source": false
              }
            ],
            "publication_date": null,
            "publisher": "Heart Failure Reviews",
            "edition": "PMC Open Access subset full-text XML, from NCBI E-utilities (Heart Failure Reviews, 2025), fetched 2026-11-18. A narrative or literature review. Used only for how the review defines cardiotoxicity from cancer treatment, what it links to and what it says about the heart conditions that can follow; its drug names, mechanisms, risk figures and cardioprotective strategies are not used.",
            "reuse_basis": "PMC Open Access subset article under the Creative Commons Attribution 4.0 licence (https://creativecommons.org/licenses/by/4.0/). The article's own license element states the licence. The XML is committed unaltered, with the citation and licence kept in the file. The raw file is committed at research/snapshots/w4k15-pmc-PMC12297282.xml.",
            "public_text": "quote",
            "replaced_by": null,
            "retirement_note": null
          }
        }
      ],
      "review": {
        "content_digest": "acb5e52089eb02cb60c4d914472b062e07c705885b2a00bca84519cec7be017b",
        "current": [],
        "conflicting": [],
        "stale": [],
        "inactive": []
      },
      "api_path": "api/v1/claims/cardio--claim-cardiotoxicity-cancer-treatment-review.json"
    }
  ],
  "decisions": [],
  "milestones": [],
  "relationships": {
    "outgoing": [
      {
        "predicate": "part_of",
        "label": "Filed under this front",
        "clinical_claim_not_fact": false,
        "family": "navigation",
        "other_entity_id": "cardio:front-medicines",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": null,
        "primary": true,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "increases_risk_of",
        "label": "A 2025 review says cancer treatment-related heart changes can lead to dilated and restrictive cardiomyopathy",
        "clinical_claim_not_fact": true,
        "family": "clinical",
        "other_entity_id": "cardio:cardiomyopathy",
        "other_entity_in_atlas": true,
        "claim_id": "cardio:claim-cardiotoxicity-cancer-treatment-review",
        "evidence": null,
        "primary": false,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "increases_risk_of",
        "label": "A 2025 review says the conditions that follow can result in heart failure",
        "clinical_claim_not_fact": true,
        "family": "clinical",
        "other_entity_id": "cardio:heart-failure",
        "other_entity_in_atlas": true,
        "claim_id": "cardio:claim-cardiotoxicity-cancer-treatment-review",
        "evidence": null,
        "primary": false,
        "role": null,
        "valid_from": null,
        "valid_to": null
      }
    ],
    "incoming": []
  },
  "page_path": "conditions/cardiotoxicity-from-cancer-treatment/",
  "context_path": "api/v1/context/cardio--cardiotoxicity-from-cancer-treatment.md"
}
